- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Chronic Spontaneous Urticaria
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
Article
Stem cells raise cancer risk
Vancouver, British Columbia - Stem cell transplants for a primary malignancy increase the 10-year risk of developing a second solid tumor, including skin cancers, researchers report.
Vancouver, British Columbia - Stem cell transplants for a primary malignancy increase the 10-year risk of developing a second solid tumor, including skin cancers, researchers report.
The risk is greater for recipients of stem cells from a female donor, according to http://Medpagetoday.com/.
Among 926 consecutive hematopoietic allograft patients seen at a single institution over 18 years, 240 had a primary cancer recurrence and 28 developed second solid malignancies. Twelve of the second tumors were of the skin, researchers said.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
